Inoveca group - Company finances
|
EUR
|
2022
From: 2022-10-06
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 41,088 | 11,520 | 44,650 |
| Profit before tax | - | - | 7,039 | 7,987 |
| Net profit | -121 | 38,751 | 6,687 | 7,508 |
| Equity | 2,379 | 41,130 | 47,817 | 55,325 |
| Liabilities | 0 | 2,100 | 118,594 | 93,911 |
| Non-current assets | 0 | 0 | 123,600 | 103,000 |
| Current assets | 2,379 | 43,230 | 35,194 | 45,892 |
| Total assets | 2,379 | 43,230 | 158,794 | 148,892 |
|
Taxes paid
|
||||
| STI taxes | - | - | 2,066 | 726 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | -72.0% | +287.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -5.1% | 89.6% | 4.2% | 5.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -5.1% | 94.2% | 14.0% | 13.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 94.3% | 58.0% | 16.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 61.1% | 17.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.1 | 2.5 | 1.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 11,520 | 44,650 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Inoveca group - Social security debts
The company had no debts to Sodra
Inoveca group - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-30 | 2025-06-02 | 0.06 |
| 2024-07-01 | 2024-10-22 | 5.31 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Inoveca group, UAB (code 306155697), a Private Limited Liability Company operating in retail sale of other medical and orthopaedic goods, reported EUR 44.6K revenue in 2025. Net profit reached EUR 7.5K, with a profit margin of 16.8%. Revenue increased sharply year on year, after EUR 11.5K in 2024, and remained above the EUR 41.1K recorded in 2023, showing a volatile but improving top-line trend. Profit followed a similar pattern: EUR 38.8K in 2023, EUR 6.7K in 2024, and EUR 7.5K in 2025. At the end of 2025, total assets stood at EUR 148.9K, supported by equity of EUR 55.3K and liabilities of EUR 93.9K. Long-term assets accounted for EUR 103.0K, while short-term assets were EUR 45.9K. Key ratios show ROE of 13.6%, ROA of 5.0%, debt-to-equity of 1.70, and asset turnover of 0.30x. Revenue per employee was EUR 44.6K, with profit per employee of EUR 7.5K.